Danaher Corporation partners with AstraZeneca to advance precision medicine tests with AI technology.
From Yahoo Finance: 2025-05-29 23:11:00
Danaher Corporation (DHR) and AstraZeneca PLC (AZN) partner to advance precision medicine with AI-powered diagnostics for targeted therapies, leveraging DHR’s Centers for Enabling Precision Medicine.
The collaboration will focus on digital and computational pathology products from Leica Biosystems, aiming to improve diagnostic accuracy and patient selection. Executives from DHR and AZN highlight the importance of AI-based diagnostics in delivering personalized healthcare solutions globally.
While DHR shows growth potential, other AI stocks may offer higher returns. For those seeking promising AI investments, consider exploring opportunities beyond DHR. Check out our report on the cheapest AI stock with significant upside potential.
Explore more investment options with the “10 Best Cancer Stocks to Invest in for Long-Term Gains” and “10 Most Oversold Stocks to Buy According to Billionaires.” No financial disclosure provided.